Concepts (128)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Borrelia burgdorferi Group | 1 | 2018 | 12 | 0.76 | Why? |
| Lyme Disease | 1 | 2018 | 102 | 0.65 | Why? |
| Skin Diseases, Infectious | 1 | 2017 | 77 | 0.62 | Why? |
| Aspergillosis | 1 | 2017 | 264 | 0.52 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.32 | Why? |
| Family | 1 | 2020 | 2909 | 0.31 | Why? |
| Genotype | 1 | 2018 | 4697 | 0.31 | Why? |
| Hemorrhagic Fever, Ebola | 1 | 2017 | 1475 | 0.29 | Why? |
| Diagnostic Tests, Routine | 1 | 2017 | 2643 | 0.29 | Why? |
| T-Lymphocytes | 1 | 2020 | 6670 | 0.25 | Why? |
| Lung Abscess | 1 | 2020 | 13 | 0.22 | Why? |
| Antibodies, Viral | 7 | 2021 | 51949 | 0.19 | Why? |
| Borrelia burgdorferi | 1 | 2018 | 31 | 0.19 | Why? |
| Ixodes | 1 | 2018 | 58 | 0.18 | Why? |
| Lupus Coagulation Inhibitor | 1 | 2020 | 262 | 0.17 | Why? |
| Multilocus Sequence Typing | 1 | 2018 | 264 | 0.17 | Why? |
| France | 7 | 2021 | 12074 | 0.17 | Why? |
| Infant, Very Low Birth Weight | 1 | 2017 | 62 | 0.17 | Why? |
| Drug Dosage Calculations | 1 | 2018 | 243 | 0.16 | Why? |
| Diseases in Twins | 1 | 2017 | 86 | 0.16 | Why? |
| Guinea | 1 | 2017 | 228 | 0.16 | Why? |
| Fluconazole | 1 | 2017 | 145 | 0.16 | Why? |
| Amphotericin B | 1 | 2017 | 256 | 0.15 | Why? |
| Gloves, Protective | 1 | 2017 | 249 | 0.15 | Why? |
| Vancomycin | 1 | 2018 | 328 | 0.15 | Why? |
| Aspergillus fumigatus | 1 | 2017 | 239 | 0.14 | Why? |
| Sex Characteristics | 1 | 2021 | 1120 | 0.13 | Why? |
| Kinetics | 1 | 2021 | 3238 | 0.12 | Why? |
| Lung Transplantation | 2 | 2020 | 1554 | 0.12 | Why? |
| Infant, Premature | 1 | 2017 | 883 | 0.12 | Why? |
| Phosphoproteins | 1 | 2021 | 4346 | 0.11 | Why? |
| Immune Evasion | 1 | 2021 | 2081 | 0.11 | Why? |
| Kidney Transplantation | 2 | 2021 | 5397 | 0.11 | Why? |
| Seroconversion | 1 | 2020 | 2515 | 0.10 | Why? |
| Antibodies, Neutralizing | 3 | 2021 | 25288 | 0.10 | Why? |
| Convalescence | 1 | 2021 | 2829 | 0.10 | Why? |
| Transplant Recipients | 3 | 2021 | 4982 | 0.10 | Why? |
| Ebolavirus | 1 | 2017 | 834 | 0.10 | Why? |
| Long-Term Care | 1 | 2021 | 2047 | 0.10 | Why? |
| Social Determinants of Health | 1 | 2020 | 1757 | 0.09 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2020 | 7868 | 0.09 | Why? |
| Time Factors | 3 | 2021 | 31397 | 0.09 | Why? |
| Immunity, Cellular | 1 | 2020 | 3614 | 0.08 | Why? |
| Antifungal Agents | 1 | 2017 | 1828 | 0.08 | Why? |
| Serologic Tests | 1 | 2020 | 4359 | 0.08 | Why? |
| Reagent Kits, Diagnostic | 1 | 2017 | 2149 | 0.08 | Why? |
| Longitudinal Studies | 1 | 2021 | 9893 | 0.08 | Why? |
| Hematologic Neoplasms | 1 | 2018 | 2105 | 0.07 | Why? |
| Immunoassay | 1 | 2020 | 4485 | 0.07 | Why? |
| Genetic Variation | 1 | 2018 | 3919 | 0.07 | Why? |
| Patient Admission | 1 | 2020 | 5250 | 0.06 | Why? |
| Male | 12 | 2021 | 367725 | 0.06 | Why? |
| Adult | 8 | 2021 | 244371 | 0.06 | Why? |
| Immunoglobulin G | 3 | 2021 | 21571 | 0.06 | Why? |
| Spike Glycoprotein, Coronavirus | 3 | 2021 | 37182 | 0.06 | Why? |
| Middle Aged | 10 | 2021 | 270681 | 0.06 | Why? |
| Health Behavior | 1 | 2020 | 4449 | 0.06 | Why? |
| Female | 11 | 2021 | 380317 | 0.06 | Why? |
| Postoperative Complications | 1 | 2020 | 5861 | 0.06 | Why? |
| Case-Control Studies | 1 | 2020 | 17671 | 0.06 | Why? |
| Europe | 1 | 2018 | 12702 | 0.06 | Why? |
| Models, Biological | 1 | 2018 | 4907 | 0.05 | Why? |
| Humans | 16 | 2021 | 930598 | 0.05 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.05 | Why? |
| Anti-Bacterial Agents | 2 | 2020 | 10083 | 0.05 | Why? |
| Sensitivity and Specificity | 2 | 2020 | 22971 | 0.05 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.05 | Why? |
| Phylogeny | 1 | 2018 | 13341 | 0.05 | Why? |
| Prospective Studies | 2 | 2021 | 43301 | 0.05 | Why? |
| Cross Infection | 1 | 2021 | 8675 | 0.05 | Why? |
| Femoral Artery | 1 | 2020 | 213 | 0.04 | Why? |
| Emollients | 1 | 2018 | 108 | 0.04 | Why? |
| Thrombosis | 1 | 2020 | 7504 | 0.04 | Why? |
| Infant, Newborn | 1 | 2017 | 23105 | 0.04 | Why? |
| Aged | 6 | 2021 | 215776 | 0.04 | Why? |
| Lower Extremity | 1 | 2020 | 593 | 0.04 | Why? |
| Pregnancy | 1 | 2017 | 23879 | 0.04 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.03 | Why? |
| Opportunistic Infections | 1 | 2020 | 602 | 0.03 | Why? |
| Immunoglobulin M | 2 | 2021 | 9091 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2021 | 27595 | 0.03 | Why? |
| Ischemia | 1 | 2020 | 901 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Patient Compliance | 1 | 2020 | 1468 | 0.03 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.03 | Why? |
| Drug Monitoring | 1 | 2018 | 1408 | 0.03 | Why? |
| Obesity | 2 | 2020 | 7388 | 0.02 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.02 | Why? |
| Epitopes | 1 | 2021 | 4113 | 0.02 | Why? |
| Bayes Theorem | 1 | 2018 | 3237 | 0.02 | Why? |
| Immunoglobulin A | 1 | 2020 | 3567 | 0.02 | Why? |
| Animals | 1 | 2018 | 78931 | 0.02 | Why? |
| Hospitals, University | 1 | 2020 | 4173 | 0.02 | Why? |
| HEK293 Cells | 1 | 2021 | 8394 | 0.02 | Why? |
| Antibody Formation | 1 | 2021 | 4038 | 0.02 | Why? |
| Life Style | 1 | 2020 | 2708 | 0.02 | Why? |
| Neutralization Tests | 1 | 2021 | 6698 | 0.02 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.02 | Why? |
| Risk Factors | 3 | 2021 | 71621 | 0.02 | Why? |
| Dyspnea | 1 | 2020 | 3847 | 0.02 | Why? |
| Survival Analysis | 1 | 2020 | 7592 | 0.02 | Why? |
| RNA, Messenger | 1 | 2021 | 5131 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2020 | 7268 | 0.02 | Why? |
| Comorbidity | 2 | 2020 | 34796 | 0.02 | Why? |
| Survival Rate | 1 | 2020 | 9206 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2020 | 6740 | 0.02 | Why? |
| Young Adult | 3 | 2020 | 93724 | 0.02 | Why? |
| India | 1 | 2021 | 11875 | 0.02 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.02 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.01 | Why? |
| Nasopharynx | 1 | 2020 | 10224 | 0.01 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.01 | Why? |
| Contact Tracing | 1 | 2020 | 8448 | 0.01 | Why? |
| Epidemics | 1 | 2020 | 6407 | 0.01 | Why? |
| Adolescent | 2 | 2020 | 86841 | 0.01 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 9335 | 0.01 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.01 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.01 | Why? |
| Retrospective Studies | 2 | 2020 | 105322 | 0.01 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |
| Child, Preschool | 1 | 2018 | 36283 | 0.01 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.01 | Why? |
| Neoplasms | 1 | 2018 | 17251 | 0.01 | Why? |
| Child | 1 | 2018 | 70012 | 0.01 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.00 | Why? |